Benjamin Hsing, Wanda French-Brown Author Article Examining Changes to IPR Rules

Articles / September 6, 2016

Partner Benjamin Hsing and Counsel Wanda French-Brown authored an article published Aug. 30, 2016, by Pharmaceutical Patent Analyst. The article, “How the New Patent Trial and Appeal Board Rules Impact the Practice of Inter Partes Reviews,” discusses the recently revised rules governing inter partes reviews (IPRs) before the Patent Trial and Appeal Board (PTAB). Hsing and French-Brown review the new requirements and conclude, “it appears that, with the new rules, patent owners will have more tools at their disposal to defeat institution of IPRs, thereby resulting in a lower percentage of IPRs being instituted in the future.”

Read the article (registration required).